// App-Quantinova.ai

e14072 : Budgetary impact of lipegfilgrastim to the Brazilian public healthcare system.

Researchers

Presenter

  • Agota Szende

Principal Investigators

  • Jason Allaire

  • Jennifer Urwongse

  • Marco Petti

  • Omar Tomey Mendez

  • Udo W. Mueller

  • Andre Vicente

  • Stephen D. Stefani

  • Boxiong Tang

Medical Centers

  • Covance, Leeds, United Kingdom

  • Generativity Solutions Group, Cary, NC

  • Covance, Washington, DC

  • Teva Pharmaceuticals, Sao Paulo, Brazil

  • Teva Pharmaceuticals, Naucalpan De Juarez Area, Mexico

  • Teva Pharmaceuticals, Inc., Ulm, Germany

  • Instituto do Cancer HMD, Porto Alegre, Brazil

  • Teva Pharmaceuticals, Frazer, PA

Locations

  • Brazil

  • Germany

  • United Kingdom

  • United States

  • Mexico

Companies

  • Generativity Solutio

  • Teva Pharmaceutical

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Lipegfilgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved